Literature DB >> 21623272

Angiosarcoma arising from right atrium: remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxel.

Akito Hata, Nobuyuki Katakami, Shiro Fujita, Masaki Kokubo, Yukihiro Imai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623272     DOI: 10.1097/JTO.0b013e318215a22b

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

1.  Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literature.

Authors:  Chao Wang; Min Shi; Chen Yang; Tao Ma; Jinling Jiang; Ying Liu; Wenqi Xi; Zhenggang Zhu; Jun Zhang
Journal:  Mol Clin Oncol       Date:  2017-08-24

2.  Angiosarcoma of the seminal vesicle: a case report of long-term survival following multimodality therapy.

Authors:  Kenneth Chang; Terence T Sio; Vishal S Chandan; Matthew J Iott; Christopher L Hallemeier
Journal:  Rare Tumors       Date:  2014-01-29

3.  Primary breast angiosarcoma: avoiding a common trap.

Authors:  Christine Desbiens; Jean-Charles Hogue; Yves Lévesque
Journal:  Case Rep Oncol Med       Date:  2011-07-06

4.  Treating the Critically Ill with Radiotherapy: Lessons Learned from a Young Woman with Cardiac Angiosarcoma.

Authors:  Emma C Fields; Bryan Squires; Harry Lomas
Journal:  Front Oncol       Date:  2017-03-02       Impact factor: 6.244

5.  Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma.

Authors:  Santino Minichillo; Maria Abbondanza Pantaleo; Margherita Nannini; Fabio Coccolo; Lidia Gatto; Guido Biasco; Giovanni Brandi
Journal:  BMC Res Notes       Date:  2015-07-30

6.  Primary cardiac angiosarcoma: a prolonged response to surgical resection followed by concurrent chemoradiotherapy with docetaxel.

Authors:  Youngwoo Jang; Joonhwan Kim; Jung Woo Shim; Eun Young Kim; Jungkeun Moon; Jungsuk An; Yang Bin Jeon; Kyu Chan Lee; Hee Kyung Ahn
Journal:  Springerplus       Date:  2016-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.